Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “IODINE 138”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

Nuclear Data Sheets for A=138☆

Experimental nuclear structure data from various reactions and decays are compiled and evaluated for all known nuclides with mass number A=138 (Sn,Sb,Te,I,Xe,Cs,Ba,La,Ce,Pr,Nd,Pm,Sm,Eu,Gd,Tb). Detailed evaluated nuclear structure information is presented for each reaction and decay and the best values combining all available data are recommended for level energies, half-lives, γ-ray energies and intensities, decay properties (energies, intensities and placement of radiations), and other spectroscopic properties. This work supersedes the previous full evaluation of A=138 by A.A. Sonzogni (2003So13).

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Closure Report for Corrective Action Unit 107: Low Impact Soil Sites, Nevada Test Site, Nevada with ROTCs 1-3

CAU 107, “Low Impact Soil Sites,” consists of 15 CASs in Areas 1, 2, 3, 4, 5, 9, 10, and 18 of the NTS. The closure alternatives included No Further Action and Closure in Place with Administrative Controls. This CR provides a summary of completed closure activities. ROTC Justification: The FFACO UR as published in the Closure Report for Corrective Action Unit 107: Low Impact Soil Sites, Nevada Test Site, Nevada (NNSA/NSO, 2009) states that the UR for CAS 18-23-02, U-18d Crater (Sulky), was implemented for assumed radioactive contamination that could cause a dose greater that 25 millirems per year. This document further clarifies that this was based on particulate releases of radionuclides identified in Radiological Effluents Released from U.S. Continental Tests, 1961 through 1992 (DOE/NV, 1996). The radionuclides listed in this document are krypton (Kr)-85, Kr-85m, Kr-87, Kr-88, rubidium (Rb)-87, strontium (Sr)-89, Sr-91, yttrium (Y)-91, iodine (I)-131, I-132, I-133, I-134, I-135, xeon (Xe)-133, Xe-135, Xe-138, cesium (Cs)-135, Cs-138, barium (Ba)-139, and Ba-140.

54 ENVIRONMENTAL SCIENCES↗

Estimation of iodine nutrition and thyroid function status in late-gestation pregnant women in the United States: Development and application of a population-based pregnancy model

Previously, a deterministic biologically-based dose-response (BBDR) pregnancy model was developed to evaluate moderate thyroid axis disturbances with and without thyroid-active chemical exposure in a near-term pregnant woman and fetus. In the current study, the existing BBDR model was adapted to include a wider functional range of iodine nutrition, including more severe iodine deficiency conditions, and to incorporate empirically the effects of homeostatic mechanisms. The extended model was further developed into a population-based model and was constructed using a Monte Carlo-based probabilistic framework. In order to characterize total (T4) and free (fT4) thyroxine levels for a given iodine status at the population-level, the distribution of iodine intake for late-gestation pregnant women in the U.S was reconstructed using various reverse dosimetry methods and available biomonitoring data. The range of median (mean) iodine intake values resulting from three different methods of reverse dosimetry tested was 196.5–219.9 μg of iodine/day (228.2–392.9 μg of iodine/day). There was minimal variation in model-predicted maternal serum T4 and ft4 thyroxine levels from use of the three reconstructed distributions of iodine intake; the range of geometric mean for T4 and fT4, was 138–151.7 nmol/L and 7.9–8.7 pmol/L, respectively. The average value of the ratio of the 97.5th percentile to the 2.5th percentile equaled 3.1 and agreed well with similar estimates from recent observations in third-trimester pregnant women in the U.S. In addition, the reconstructed distributions of iodine intake allowed us to estimate nutrient inadequacy for late-gestation pregnant women in the U.S. via the probability approach. The prevalence of iodine inadequacy for third-trimester pregnant women in the U.S. was estimated to be between 21% and 44%. Taken together, the current work provides an improved tool for evaluating iodine nutritional status and the corresponding thyroid function status in pregnant women in the U.S. This model enables future assessments of the relevant risk of thyroid hormone level perturbations due to exposure to thyroid-active chemicals at the population-level. - Highlights: • A population-based thyroid function model for pregnant women was developed. • The model was used specifically study the late-gestation pregnant women in the U.S. • The prevalence of iodine inadequacy was estimated in the sub-population studied. • Developed model well predicts trimester-specific thyroid hormone reference ranges. • The model can be further used to study thyroid perturbations at a population level.

60 APPLIED LIFE SCIENCES↗

g-factor and spin-parity assignments of excited states in the N=83 isotones {sup 135}Te, {sup 136}I, {sup 137}Xe, and {sup 138}Cs

The g factor of the 15/2{sup -} state in {sup 137}Xe was measured for the first time by using a newly developed technique for measuring angular correlations with Gammasphere. Spins and parities were assigned to several levels in the N=83 isotones {sup 135}Te, {sup 136}I, {sup 137}Xe, and {sup 138}Cs. The calculated g factor in the shell-model frame is in good agreement with the measured one in the present work. Shell-model calculations also support our spin-parity assignments.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Improved Cumulative Fission Yield Measurements with Fission Spectrum Neutrons on 235 U

Two isotopically-characterized targets of high-purity (99.84±0.03%) 235 U-oxide and a neutron dosimetry package were exposed to a pulsed neutron irradiation using the Godiva critical assembly at the National Criticality Experiments Research Center. Following irradiation, the fissioned targets were counted with a broad-energy germanium detector. Estimates of the total fissions for each target were made using measurements of well-known fission products. The total fission values were then used to measure the fission yields of 21 fission products with half-lives between 636 and 119,700 seconds. Mean values of seventeen of the measured fission products fell within the 95% confidence level of the Evaluated Nuclear Data Files VII.1/b (ENDF/B-VII.1) using the larger of the two uncertainties: 84g Br, 89 Rb, 91 Sr, 93 Y, 97 Zr, 101 Mo, 105 Ru, 128 Sn, 129 Sb, 130g Sb, 131 Sb, 131m Te, 133 I, 135 I, 141 Ba, 142 Ba, and 142 La. Seven isotopes were measured to better precision than is listed in the ENDF/B-VII.1 database: 89 Rb, 93 Y, 128 Sn, 129 Sb, 130g Sb, 131m Te, and 133 I. Four of the measured isotopes were found to be statistically different from the ENDF/B-VII.1 database: 94 Y, 134 Te, 134 I, and 138 Xe. Two of the isotopic analyses conducted in this paper fit the parent and daughter data simultaneously. The parent-daughter pairs measured in this way were the 134 Te/I and 142 Ba/La pairs. The fission yield results obtained in this way are unique, especially for 134 I, because the parent and daughter half-lives are so close. Here, given the limited number of direct measurements of the 134 Te/I pair from fast neutron induced fission and the seemingly high estimate for 134 Te from previous work, it is likely that the value in this paper is more accurate; however, additional measurements of this pair are needed to validate this assertion.

42 ENGINEERING↗

BEDVH--A method for evaluating biologically effective dose volume histograms: Application to eye plaque brachytherapy implants

Purpose: A method is introduced to examine the influence of implant duration T, radionuclide, and radiobiological parameters on the biologically effective dose (BED) throughout the entire volume of regions of interest for episcleral brachytherapy using available radionuclides. This method is employed to evaluate a particular eye plaque brachytherapy implant in a radiobiological context. Methods: A reference eye geometry and 16 mm COMS eye plaque loaded with {sup 103}Pd, {sup 125}I, or {sup 131}Cs sources were examined with dose distributions accounting for plaque heterogeneities. For a standardized 7 day implant, doses to 90% of the tumor volume ( {sub TUMOR}D{sub 90}) and 10% of the organ at risk volumes ( {sub OAR}D{sub 10}) were calculated. The BED equation from Dale and Jones and published {alpha}/{beta} and {mu} parameters were incorporated with dose volume histograms (DVHs) for various T values such as T = 7 days (i.e., {sub TUMOR} {sup 7}BED{sub 10} and {sub OAR} {sup 7}BED{sub 10}). By calculating BED throughout the volumes, biologically effective dose volume histograms (BEDVHs) were developed for tumor and OARs. Influence of T, radionuclide choice, and radiobiological parameters on {sub TUMOR}BEDVH and {sub OAR}BEDVH were examined. The nominal dose was scaled for shorter implants to achieve biological equivalence. Results: {sub TUMOR}D{sub 90} values were 102, 112, and 110 Gy for {sup 103}Pd, {sup 125}I, and {sup 131}Cs, respectively. Corresponding {sub TUMOR} {sup 7}BED{sub 10} values were 124, 140, and 138 Gy, respectively. As T decreased from 7 to 0.01 days, the isobiologically effective prescription dose decreased by a factor of three. As expected, {sub TUMOR} {sup 7}BEDVH did not significantly change as a function of radionuclide half-life but varied by 10% due to radionuclide dose distribution. Variations in reported radiobiological parameters caused {sub TUMOR} {sup 7}BED{sub 10} to deviate by up to 46%. Over the range of {sub OAR}{alpha}/{beta} values, {sub OAR} {sup 7}BED{sub 10} varied by up to 41%, 3.1%, and 1.4% for the lens, optic nerve, and lacrimal gland, respectively. Conclusions: BEDVH permits evaluation of the relative biological effectiveness for brachytherapy implants. For eye plaques, {sub TUMOR}BEDVH and {sub OAR}BEDVH were sensitive to implant duration, which may be manipulated to affect outcomes.

61 RADIATION PROTECTION AND DOSIMETRY↗